World CDx 2026 has ended. This guide stays up as the record of who was there. Next: World CDx 2027, Aug 30 – Sep 2, 2027 in Boston
Agenus at World CDx 2026
Oct 5–8, 2026 Boston, MA ~900 attendees Website
Agenus takes part in 2 sessions at World CDx 2026 in Boston. Its sessions cover biomarker strategy for a biotech working in precision oncology. Most concrete is linking several kinds of baseline biomarkers to clinical outcomes in patients with cold, treatment-resistant tumors given an Fc-enhanced anti-CTLA-4 antibody.
| Organization | World CDx 2026 Attendance |
|---|---|
Agenus Lexington, MA | |
Biotechnology company developing immuno-oncology antibodies, including an Fc-enhanced anti-CTLA-4 therapy, for cancer. | Panel Wed Oct 7 3:10pm Navigating Biomarker Complexity as a Biotech to Build Smarter Precision Oncology Strategies that Maximize Clinical & Commercial Impact Biomarker discovery & translationDrug–diagnostic commercialization & access Talk Thu Oct 8 11:30am Integrating Multimodal Baseline Biomarkers with Clinical Outcomes in Patients with Cold, Refractory Tumors, Treated with Fc-Enhanced Anti–CTLA-4 Antibody Therapy Biomarker discovery & translation |
Instantly find 20 buyers from Agenus
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by World CDx or its organizers. Submit a correction